# Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

> **NCT00825045** · NA · UNKNOWN · sponsor: **Centre for Addiction and Mental Health** · enrollment: 14 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorder

## Interventions

- **DRUG:** risperidone

## Key facts

- **NCT ID:** NCT00825045
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2020-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00825045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00825045, "Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00825045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*